HADHA and fetal growth restriction: The more striking reductions in LCHAD mRNA expression, when compared to the controls, were found in the analysis of the fetal side, with a 45.4% decrease in the EOPE and IUGR cases, followed by −43.0% in MPE and in the overall pre-eclampsia sample, −40.7% in LOPE, −39.3% in SPE, and −36.2% in NIUGR.